vs

Side-by-side financial comparison of HEALTHY CHOICE WELLNESS CORP. (HCWC) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.

LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $18.7M, roughly 1.7× HEALTHY CHOICE WELLNESS CORP.). HEALTHY CHOICE WELLNESS CORP. runs the higher net margin — -8.9% vs -32.1%, a 23.2% gap on every dollar of revenue. LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-927.1K).

LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.

HCWC vs LFCR — Head-to-Head

Bigger by revenue
LFCR
LFCR
1.7× larger
LFCR
$31.1M
$18.7M
HCWC
Higher net margin
HCWC
HCWC
23.2% more per $
HCWC
-8.9%
-32.1%
LFCR
More free cash flow
LFCR
LFCR
$952.1K more FCF
LFCR
$25.0K
$-927.1K
HCWC

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
HCWC
HCWC
LFCR
LFCR
Revenue
$18.7M
$31.1M
Net Profit
$-1.7M
$-10.0M
Gross Margin
39.1%
25.0%
Operating Margin
-7.6%
-9.9%
Net Margin
-8.9%
-32.1%
Revenue YoY
-4.5%
Net Profit YoY
-52.0%
EPS (diluted)
$-0.05
$-0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCWC
HCWC
LFCR
LFCR
Q4 25
$18.7M
Q3 25
$19.0M
$31.1M
Q2 25
$20.2M
Q1 25
$20.3M
$35.2M
Q4 24
$32.6M
Q3 24
$18.2M
$24.7M
Q1 24
$35.7M
Q4 23
$30.1M
Net Profit
HCWC
HCWC
LFCR
LFCR
Q4 25
$-1.7M
Q3 25
$-1.2M
$-10.0M
Q2 25
$-339.4K
Q1 25
$-712.4K
$-14.8M
Q4 24
$-6.6M
Q3 24
$-2.7M
$-16.2M
Q1 24
$15.6M
Q4 23
$14.2M
Gross Margin
HCWC
HCWC
LFCR
LFCR
Q4 25
39.1%
Q3 25
38.8%
25.0%
Q2 25
40.1%
Q1 25
38.8%
28.0%
Q4 24
34.0%
Q3 24
38.4%
21.8%
Q1 24
33.3%
Q4 23
33.0%
Operating Margin
HCWC
HCWC
LFCR
LFCR
Q4 25
-7.6%
Q3 25
-3.2%
-9.9%
Q2 25
-0.2%
Q1 25
-2.0%
-25.7%
Q4 24
-6.0%
Q3 24
-2.0%
-46.9%
Q1 24
-2.5%
Q4 23
-4.9%
Net Margin
HCWC
HCWC
LFCR
LFCR
Q4 25
-8.9%
Q3 25
-6.4%
-32.1%
Q2 25
-1.7%
Q1 25
-3.5%
-42.0%
Q4 24
-20.2%
Q3 24
-14.6%
-65.7%
Q1 24
43.8%
Q4 23
47.2%
EPS (diluted)
HCWC
HCWC
LFCR
LFCR
Q4 25
$-0.05
Q3 25
$-0.09
$-0.29
Q2 25
$-0.03
Q1 25
$-0.07
$-0.47
Q4 24
$-0.25
Q3 24
$-0.29
$-0.53
Q1 24
$0.42
Q4 23
$0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCWC
HCWC
LFCR
LFCR
Cash + ST InvestmentsLiquidity on hand
$3.0M
$18.9M
Total DebtLower is stronger
$7.3M
$136.0M
Stockholders' EquityBook value
$7.3M
$-10.5M
Total Assets
$33.5M
$235.2M
Debt / EquityLower = less leverage
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCWC
HCWC
LFCR
LFCR
Q4 25
$3.0M
Q3 25
$3.0M
$18.9M
Q2 25
$4.7M
Q1 25
$1.8M
$5.4M
Q4 24
$9.5M
Q3 24
$1.8M
Q1 24
Q4 23
Total Debt
HCWC
HCWC
LFCR
LFCR
Q4 25
$7.3M
Q3 25
$8.5M
$136.0M
Q2 25
$9.7M
Q1 25
$10.6M
$124.9M
Q4 24
$111.3M
Q3 24
$11.6M
$106.3M
Q1 24
$97.1M
Q4 23
$92.9M
Stockholders' Equity
HCWC
HCWC
LFCR
LFCR
Q4 25
$7.3M
Q3 25
$5.9M
$-10.5M
Q2 25
$5.8M
Q1 25
$2.1M
$2.2M
Q4 24
$15.4M
Q3 24
$2.9M
$-3.9M
Q1 24
$17.7M
Q4 23
$1.4M
Total Assets
HCWC
HCWC
LFCR
LFCR
Q4 25
$33.5M
Q3 25
$33.7M
$235.2M
Q2 25
$36.4M
Q1 25
$34.1M
$237.7M
Q4 24
$255.4M
Q3 24
$33.2M
$246.8M
Q1 24
$246.2M
Q4 23
$245.8M
Debt / Equity
HCWC
HCWC
LFCR
LFCR
Q4 25
1.00×
Q3 25
1.43×
Q2 25
1.69×
Q1 25
5.01×
56.05×
Q4 24
7.20×
Q3 24
3.95×
Q1 24
5.49×
Q4 23
65.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCWC
HCWC
LFCR
LFCR
Operating Cash FlowLast quarter
$-855.1K
$1.8M
Free Cash FlowOCF − Capex
$-927.1K
$25.0K
FCF MarginFCF / Revenue
-5.0%
0.1%
Capex IntensityCapex / Revenue
0.4%
5.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$675.4K
$-16.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCWC
HCWC
LFCR
LFCR
Q4 25
$-855.1K
Q3 25
$-308.7K
$1.8M
Q2 25
$1.1M
Q1 25
$1.1M
$1.2M
Q4 24
$-6.1M
Q3 24
$-613.0K
Q1 24
$-1.4M
Q4 23
$1.3M
Free Cash Flow
HCWC
HCWC
LFCR
LFCR
Q4 25
$-927.1K
Q3 25
$-351.3K
$25.0K
Q2 25
$988.6K
Q1 25
$965.3K
$-4.3M
Q4 24
$-8.6M
Q3 24
$-4.0M
Q1 24
$-7.8M
Q4 23
$-3.0M
FCF Margin
HCWC
HCWC
LFCR
LFCR
Q4 25
-5.0%
Q3 25
-1.8%
0.1%
Q2 25
4.9%
Q1 25
4.8%
-12.1%
Q4 24
-26.3%
Q3 24
-16.3%
Q1 24
-21.8%
Q4 23
-9.9%
Capex Intensity
HCWC
HCWC
LFCR
LFCR
Q4 25
0.4%
Q3 25
0.2%
5.6%
Q2 25
0.4%
Q1 25
0.6%
15.5%
Q4 24
7.5%
Q3 24
13.9%
Q1 24
17.8%
Q4 23
14.1%
Cash Conversion
HCWC
HCWC
LFCR
LFCR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q1 24
-0.09×
Q4 23
0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCWC
HCWC

Retail Grocery$17.1M91%
Food Service Restaurant$1.7M9%

LFCR
LFCR

Transferred At Point In Time$26.6M85%
Transferred Over Time$4.5M15%

Related Comparisons